Hepatitis B and C Infection in International Travelers

ConclusionsThis review demonstrates international travelers are at risk of HBV and HCV infection and provides evidence‐based information enabling health practitioners to provide more appropriate pre‐travel advice. HBV vaccination should be considered in all travelers to countries with a moderate to high HBV prevalence (HBsAg ≥ 2%) and the risk and benefits discussed with the individuals in consultation with the health practitioner. There is no duration of travel without risk of HBV infection. However, it is apparent that those travelers with a longer duration of travel are at greatest risk of HBV infection (ie, expatriates). Travelers should also receive advice regarding the modes of transmission and the activities that place them at risk of both HBV and HCV infection.
Source: Journal of Travel Medicine - Category: Infectious Diseases Authors: Tags: REVIEW Source Type: research